The WADA’s Executive Committee, including FIS President Gian Franco Kasper, has approved the List of Prohibited Substances and Methods for 2010. Meeting in Montreal (CAN) last weekend, the WADA Executive was pleased to see that the 2010 List reflects the latest scientific advances. The new List will now be officialized and published on WADA’s Website by 1st October 2009. It will take effect on 1st January 2010.
The 2010 List offers some changes compared to the 2009 List. In particular, the status of salbutamol, a beta-2 agonist, will change. Salbutamol – a specified substance – will be permitted and its use by inhalation will no longer require a Therapeutic Use Exemption (TUE) but rather a simplified declaration of use. In addition, the 2010 List will no longer prohibit supplemental oxygen (hyperoxia). The status of platelet-derived preparations (e.g. Platelet Rich Plasma, “blood spinning”) has also been clarified. Finally, pseudoephedrine was reintroduced to the List as a specified stimulant. Given the wide availability of medicines containing pseudoephedrine, information and education campaigns by WADA’s stakeholders are recommended.
Among other items, 34 research programs were selected for funding by WADA. The Executive Committee further approved a special book project to be commissioned by WADA as part of the Agency’s tenth anniversary. This book – to be written by Dr Thomas Murray, President of the Hastings Center in Garrison, United States – will address the ethical issues surrounding doping and doping-free sport. It will seek to provide an alternative vision of the future of sport based on ethical reasoning and an appreciation of the forces that shape elite sport.
WADA leadership next meets on 1st-2nd December in Stockholm (SWE) which will also mark the organisation’s tenth anniversary.